Chair/bedside diagnosis of oral and respiratory tract infections, and identification of antibiotic resistances for personalised monitoring and treatment


0
PARTNERS
0
COUNTRIES
0.6
MILLION EUROS FROM THE E.U
0
YEARS
0
UNTIL 2019

Progress
100%

LATEST NEWS


The end of an era, opening the doors to a more optimistic future in diagnostics

The DIAGORAS project came to an end on 31.05.2019, after 48 months of lifetime.

Project objectives were achieved spanning the entire value chain of: sample handling, nucleic acid assays, protein assays, microfluidic integration and manufacturing, readout equipment, IT analysis and reporting interface, as well as validation with reference and clinical samples. Furthermore, numerous dissemination actions promoted the project, which ended with noteworthy exploitation potentials. In addition, new, unplanned developments were initiated, opening the way for future projects and collaborations in the fields of oral and respiratory tract infections. All partners are greatly acknowledged for their high quality work, commitment, dedication and excellent collaborative spirit!

Click here to learn more about our main achievements!



OUR GOAL

Developing a Point-of-Care microbiological diagnostic device for use in general practitioner offices, dental clinics and practices, and hospital emergency rooms.


LEARN MORE
PROVIDE US YOUR NEEDS

OBJECTIVES


The DIAGORAS project develops a device that will allow on-site, rapid and accurate prescription of personalized treatment procedures for respiratory and oral infections.

SPEEDING UP THE TIME OF DIAGNOSTIC

by providing interpretable results within 1 hour

IMPROVING ANTIBIOTIC USE

by identifying the causative agent, either virus or bacterium

LIGHTENING THE BURDEN OF THE HEALTHCARE SYSTEM

by offering low costs compared to existing diagnostic tools and methods

REDUCING PATIENT MORBIDITY

by allowing rapid and accurate Point-of-Care infectious disease diagnostics

OUTCOMES


DIAGORAS intends to bring disruptive changes in the current practice of the medical field.

PARTNERS


Hahn Schickard ClincaGeno Universität Zurich Erasmus MC Sparks&Co
MagnaMedics Austrian Institute of Technology Biovendor Karolinska Institutet